Guest Post: JACC Retracts AF Ablation Trial

Editor’s note: This guest post by Dalmeet Singh Chawla is reprinted with the permission of Retraction Watch, where it was originally published in a slightly different form. –Lead author Andrea Natale claims undue industry influence. The Journal of the American College of Cardiology (JACC) has retracted a recently published paper that questioned the effectiveness of a treatment for atrial…

Click here to continue reading…

Study Explores Role of Periprocedural Dabigatran in AF Ablation

Updated with a comment from John Mandrola– As dabigatran becomes more widely used in atrial fibrillation (AF) patients, electrophysiologists are now trying to figure out how to handle anticoagulation in patients taking dabigatran (Pradaxa) for whom AF ablation is planned. In a new study published in the Journal of the American College of Cardiology, Dhanunjaya Lakkireddy and colleagues…

Click here to continue reading…